Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Khademi, Ehteram, Elham Alehabib, Ehsan Esmaili Shandiz, Azadeh Ahmadifard, Monavvar Andarva, Javad Jamshidi, Simin Rahimi-Aliabadi et al. "Support for “disease-only” genotypes and excess of homozygosity at the CYTH4 primate-specific GTTT-repeat in schizophrenia." Genetic testing and molecular biomarkers 21, no. 8 (2017): 485-490.

Comer, Ashley L., Micaël Carrier, Marie-Ève Tremblay, and Alberto Cruz-Martín. "The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation." Frontiers in Cellular Neuroscience 14 (2020): 274.

Miller, Brian J., and David R. Goldsmith. "Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology." Biomarkers in Neuropsychiatry 1 (2019): 100006.

Sneeboer, Marjolein AM, Thalia van der Doef, Manja Litjens, N. B. B. Psy, J. Melief, Elly M. Hol, René S. Kahn, and Lot D. de Witte. "Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker?." Schizophrenia research 215 (2020): 167-172.

Mezquida, G., R. Penades, B. Cabrera, G. Savulich, A. Lobo, A. González-Pinto, M. J. Penzol et al. "Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders." European Psychiatry 38 (2016): 61-69.

Kadasah, Saeed, Misbahul Arfin, Sadaf Rizvi, Mohammed Al-Asmari, and Abdulrahman Al-Asmari. "Tumor necrosis factor-? and-? genetic polymorphisms as a risk factor in Saudi patients with schizophrenia." Neuropsychiatric disease and treatment 13 (2017): 1081.

Garcia?Rizo, Clemente, Marta Casanovas, Emilio Fernandez?Egea, Cristina Oliveira, Ana Meseguer, Bibiana Cabrera, Gisela Mezquida, Miquel Bioque, Brian Kirkpatrick, and Miquel Bernardo. "Blood cell count in antipsychotic?naive patients with non?affective psychosis." Early intervention in psychiatry 13, no. 1 (2019): 95-100.

Grochowska, Marta, Marcin Wojnar, and Marek Radkowski. "The gut microbiota in neuropsychiatric disorders." Acta Neurobiol Exp (Wars) 78, no. 2 (2018): 69-81.

Gragnoli, C., G. M. Reeves, John Reazer, and T. T. Postolache. "Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity." Translational psychiatry 6, no. 4 (2016): e785-e785.

Khandaker, Golam M., Stanley Zammit, Stephen Burgess, Glyn Lewis, and Peter B. Jones. "Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort." Brain, behavior, and immunity 69 (2018): 264-272.

Zhu, Feng, Yanmei Ju, Wei Wang, Qi Wang, Ruijin Guo, Qingyan Ma, Qiang Sun et al. "Metagenome-wide association of gut microbiome features for schizophrenia." Nature communications 11, no. 1 (2020): 1-10.

Hui, Chin W., Abygaël St-Pierre, Hassan El Hajj, Yvan Remy, Sébastien S. Hébert, Giamal N. Luheshi, Lalit K. Srivastava, and Marie-Ève Tremblay. "Prenatal immune challenge in mice leads to partly sex-dependent behavioral, microglial, and molecular abnormalities associated with schizophrenia." Frontiers in molecular neuroscience 11 (2018): 13.

Misiak, B?a?ej, Bart?omiej Sta?czykiewicz, Kamila Kotowicz, Janusz K. Rybakowski, Jerzy Samochowiec, and Dorota Frydecka. "Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review." Schizophrenia research 192 (2018): 16-29.

Sz?cs, Anna, András Attila Horváth, Dániel Fabó, G. Szabó, Andrea Kovács, and Péter Halász. "Pszichiátriai zavarok epilepsziában: klinikai jelenségek." (2017).

Greenhalgh, Anne Marie, Leticia Gonzalez-Blanco, Clemente Garcia-Rizo, Emilio Fernandez-Egea, Brian Miller, Miguel Bernardo Arroyo, and Brian Kirkpatrick. "Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis." Schizophrenia research 179 (2017): 57-63.

Ogyu, Kamiyu, Shin Kurose, Hiroyuki Uchida, Kousuke Kanemoto, Masaru Mimura, and Hiroyoshi Takeuchi. "Clinical features of catatonic non-convulsive status epilepticus: A systematic review of cases." Journal of Psychosomatic Research (2021): 110660.

Xu, Shuyin, Bangshan Liu, and Yan Zhang. "Effectiveness of mental therapy for poor medication adherence in depression: A review." Tropical Journal of Pharmaceutical Research 19, no. 8 (2020): 1785-1792.

Isohanni, Matti, Erika Jääskeläinen, Brian J. Miller, Anja Hulkko, Jari Tiihonen, Hans?Jurgen Möller, Sirpa Hartikainen, Sanna Huhtaniska, and Johannes Lieslehto. "Medication management of antipsychotic treatment in schizophrenia—A narrative review." Human Psychopharmacology: Clinical and Experimental 36, no. 2 (2021): e2765.

Gambalunga, Francesca, Laura Iacorossi, Ippolito Notarnicola, Valeria Serra, Michela Piredda, and Maria Grazia De Marinis. "Mobile Health in Adherence to Oral Anticancer Drugs: A Scoping Review." CIN: Computers, Informatics, Nursing 39, no. 1 (2021): 17-23.

Daniëls, Naomi EM, Laura MJ Hochstenbach, Catherine van Zelst, Marloes A. van Bokhoven, Philippe AEG Delespaul, and Anna JHM Beurskens. "Factors That Influence the Use of Electronic Diaries in Health Care: Scoping Review." JMIR mHealth and uHealth 9, no. 6 (2021): e19536.